Skip to main content
Thorax logoLink to Thorax
. 1995 Jan;50(1):103.

AUTHORS' REPLY

H A M Kerstjens 1, D S Postma 1
PMCID: PMC473745

Full text

PDF

Page 103

103

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Selroos O., Sovijärvi A. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med. 1994 Sep 15;331(11):700–705. doi: 10.1056/NEJM199409153311103. [DOI] [PubMed] [Google Scholar]
  2. Kerstjens H. A., Brand P. L., Hughes M. D., Robinson N. J., Postma D. S., Sluiter H. J., Bleecker E. R., Dekhuijzen P. N., de Jong P. M., Mengelers H. J. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group. N Engl J Med. 1992 Nov 12;327(20):1413–1419. doi: 10.1056/NEJM199211123272003. [DOI] [PubMed] [Google Scholar]
  3. Lacronique J., Renon D., Georges D., Henry-Amar M., Marsac J. High-dose beclomethasone: oral steroid-sparing effect in severe asthmatic patients. Eur Respir J. 1991 Jul;4(7):807–812. [PubMed] [Google Scholar]
  4. Pauwels R. A., Löfdahl C. G., Pride N. B., Postma D. S., Laitinen L. A., Ohlsson S. V. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design. Eur Respir J. 1992 Nov;5(10):1254–1261. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES